1.
José Luis Ordoñez-Librado, Ana Luisa Gutierrez-Valdez, Jesus Espinosa-Villanueva, Enrique Montiel-Flores, Patricia Aley-Medina, Javier Sánchez-Betancourt, et al. L-DOPA/Capsazepine or L-DOPA/Rimonabant Co-Administration in an Experimental Parkinson Disease Model: Behavioral and Cellular Consequences. IDMMR-V5 [Internet]. 2022 Feb. 4 [cited 2026 Jun. 17];:35-60. Available from: https://stm.bookpi.org/IDMMR-V5/article/view/5580